Atlas Trials

Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer

Clinical trial NCT05912062 · UNKNOWN

Trial details

NCT number
NCT05912062
Sponsor
Institut Català d'Oncologia
Status
UNKNOWN
Study type
OBSERVATIONAL
HER2-positive Breast CancerNeoplasmsBreast Cancer
Start date
2021-03-22
Primary completion
2024-06-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.